Skip to main content
. 2011 May 25;3:9. doi: 10.1186/1758-5996-3-9

Table 3.

Clinical Characteristics of the Study Subjects.

Variables* Normoalbuminuria
n = 1150
Microalbuminuria
n = 226
Macroalbuminuria
n = 38
p
Male 609 (53.0) 118 (52.2) 23 (60.5) 0.631
Age (years) 55.7 ± 10.0 58.6 ± 9.6 59.6 ± 9.67 < 0.001
Duration of DM (years) 5.2 ± 6.1 6.6 ± 6.6 8.9 ± 6.2 < 0.001
BMI (kg/m2) 25.5 ± 3.9 24.9 ± 4.5 23.5 ± 3.8 0.004
SBP (mm of Hg) 137.4 ± 19.9 145.6 ± 22.8 150.4 ± 23.0 < 0.001
DBP (mm of Hg) 81.5 ± 11.2 84.0 ± 11.5 83.8 ± 12.9 0.005
HbA1c (gm %) 8.0 ± 2.1 9.0 ± 2.3 9.0 ± 2.3 < 0.001
Serum TC 186.1 ± 40.4 186.8 ± 39.3 196.5 ± 56.9 0.299
Serum HDL 39.2 ± 10.2 38.8 ± 9.3 42.5 ± 13.2 0.119
Serum TGL 153.4 ± 104.4 156.1 ± 80.4 148.9 ± 75.2 0.896
Presence of DR 162 (14.1) 70 (31.0) 23 (60.5) < 0.001
Presence of Sight threatening DR 16 (9.9) 15 (21.4) 14 (60.9) < 0.001

Abbreviations: DM, Diabetes Mellitus; BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; HbA1c, Glycosylated Hemoglobin; DR, Diabetic Retinopathy

* Data are means ± SD or n (%)

HHS Vulnerability Disclosure